Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Adolescent health programs receive only a tiny share of international aid, finds research

Adolescent health programs receive only a tiny share of international aid, finds research

Researchers identify role of infection-fighting cells in inflamed and damaged tissue

Researchers identify role of infection-fighting cells in inflamed and damaged tissue

CHOP experts identify new autoimmune disorder along with personalized treatment for young patient

CHOP experts identify new autoimmune disorder along with personalized treatment for young patient

EKF Diagnostics to showcase new Stanbio GA assay kit at AACC 2018

EKF Diagnostics to showcase new Stanbio GA assay kit at AACC 2018

Scientists find people's assumptions about DNA repair after CRISPR editing to be wrong

Scientists find people's assumptions about DNA repair after CRISPR editing to be wrong

FDA approves first therapy for patients with rare tumors of the adrenal gland

FDA approves first therapy for patients with rare tumors of the adrenal gland

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Researchers identify enzyme as potential new drug target for blood disorders

Researchers identify enzyme as potential new drug target for blood disorders

New study suggests testing urine and blood serum as better way to diagnose myeloma

New study suggests testing urine and blood serum as better way to diagnose myeloma

EKF Diagnostics publishes new capillary blood sampling guide

EKF Diagnostics publishes new capillary blood sampling guide

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Study points to dangers of feeding non-dairy drink to infants

Study points to dangers of feeding non-dairy drink to infants

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Music therapy shows promise for improving lives of people with sickle cell disease

Music therapy shows promise for improving lives of people with sickle cell disease

Synthetic gene reveals potential therapeutic target for rare, inherited disease

Synthetic gene reveals potential therapeutic target for rare, inherited disease

CRISPR-Cas9 technique may raise cancer risk

CRISPR-Cas9 technique may raise cancer risk

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.